Tina Zerilli, Pharm.D.
Associate Professor of Pharmacy Practice
Director of Assessment Tina.Zerilli@liu.edu
Pharm.D., Arnold & Marie Schwartz College of Pharmacy and Health Sciences, LIU Pharmacy
Dr. Tina Zerilli joined LIU Pharmacy in July 2002 as a drug information specialist at the College’s International Drug Information Center (IDIC), having graduated from the College that same year at the top of her class. During her tenure in this administrative position she was a recipient of the College’s Founder’s Award for Administration and Supporting Staff (2006). She was later promoted to a faculty position in 2007 with her primary practice site being the IDIC. In this capacity, she has been involved in the didactic and experiential education of Doctor of Pharmacy students, specifically in the area of drug information and literature evaluation.
Beyond her teaching responsibilities, Dr. Zerilli has been intimately involved in assessment activities at the College. She helped develop and implement the College’s plan for curricular assessment while serving as chair of the Curricular Assessment Committee. Most recently, Dr. Zerilli served as a co-chair of the College’s self-study for re-accreditation by the Accreditation Council for Pharmacy Education. She is currently serving as chair of the Assessment Committee, the body responsible for developing and executing the College’s programmatic assessment plan.
Professionally, Dr. Zerilli is a member of several organizations including Rho Chi, the Academic Honor Society in Pharmacy. As a licensed pharmacist in the state of New York she has served as a consultant to a long-term care facility in addition to working in a community pharmacy setting. In line with her areas of expertise, Dr. Zerilli’s research interests have revolved around the use of drug information resources by both healthcare professionals and the lay public. In addition to the field of drug information Dr. Zerilli also strives to contribute to the scientific literature as it pertains globally to clinical pharmacy practice, and to the educational literature as it pertains to assessment practices.
Research interests have revolved around the use of drug information resources by both healthcare professionals and the lay public, and global topics relevant to clinical pharmacy practice. More recently, research has centered on educational practices as it pertains to programmatic and curricular assessment. Current focus is on the use of standardized patients in improving students' pharmacy practice skills.
Zerilli T, Ocheretyaner E. Apremilast (Otezla): A new oral treatment for adults with psoriasis and psoriatic arthritis. P & T. 2015; 40(8):495-500.
Khaybullina D, Patel A, Zerilli T, Riociguat: a Novel Agent for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. P & T. 2014; 39(11):749-758.
Grossman S, Zerilli T, Health and medication information resources on the World Wide Web., J Pharm Pract. 2013; 26(2):85-94.
Kirschenbaum HL, Zerilli T. Assessment of full-time faculty preceptors by colleges and schools of pharmacy in the United States and Puerto Rico., Am J Pharm Educ. 2012; 76(8):148.
Nathan JP, Schilit S, Zerilli T, Shah B, Plotkin P, Tykhonova I. Functions performed by paid pharmacy interns in hospitals in the state of New York. Am J Health Syst Pharm. 2011; 68:165-168.
Rosenberg J, Schilit S, Nathan J, Zerilli T, Mcguire H. Update on the status of 89 drug information centers in the United States. Am J Health Syst Pharm. 2009; 66:1718-1722.
Zerilli T, Pyon EY. Sitagliptin phosphate: a DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. Clin Ther. 2008; 30(4):786 (author reply to letter).
Zerilli T, Pyon EY. Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. Clin Ther. 2007; 29:2614-2634.
Nathan JP, Zerilli T, Cicero LA, Rosenberg JM. Patients’ use and perception of medication information leaflets. Ann Pharmacother. 2007; 41:777-782.
Rosenberg JM, Zerilli T, Nathan JP, Mcguire H. Use of statins and gemfibrozil in patients with type 2 diabetes mellitus and cardiovascular risk factors attending adult day health care centers: an opportunity for pharmacists. Consult Pharm. 2007; 22:38-44.
Nathan JP, Cicero LA, Koumis T, Rosenberg JM, Feifer S, Maltz F. Availability of and attitudes towards resources on alternative medicine products in the community pharmacy setting. J Am Pharm Assoc. 2005; 45:734-739.
Koumis T, Samuel S. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin Ther. 2005; 27:377-392.
Koumis T, Rosenberg JM. Update of directory of drug information centers [letter]. Am J Health-Syst Pharm. 2005; 62:1348.
Koumis T, Cicero LA, Nathan JP, Rosenberg JM. Directory of pharmacist-operated drug information centers in the United States-2003. Am J Health-Syst Pharm. 2004; 61:2033-2042.
Rosenberg JM, Koumis T, Nathan JP, Cicero LA, Mcguire H. Current status of pharmacist-operated drug information centers in the United States. Am J Health-Syst Pharm. 2004; 61:2023-2032.
Koumis T, Nathan JP, Rosenberg JM, Cicero LA. Strategies for the prevention and treatment of statin-induced myopathy- is there a role for ubiquinone supplementation? Am J Health-Syst Pharm. 2004; 61:515-519.
Zerilli T, He A, Nathan JP, Grossman S. To substitute or not to substitute: That is the question. Pharmacy Times. 2011; March:68,70,72.
Agojo MC, Zerilli T, Nathan JP, Cicero LA. What’s the latest in vaccine therapy. Drug Topics. 2006; 150(23):39-40.
Nathan JP, Koumis T, Rosenberg JMR. Sublingual nitroglycerin – are we counseling patients properly? Drug Topics. 2005; 149(17):16.
Koumis T, Nathan JP, Rosenberg JM. What is bioidentical HRT and is there evidence to support its use? Drug Topics. 2005; 149(9):29.
Koumis T, Cicero LA, Nathan JP, Rosenberg JM. What are the current and emerging strategies to improve low HDL-C levels? Drug Topics. 2004; 148(21):20-21.
Shah M, Nathan JP, Koumis T, Rosenberg JM. Was the FDA justified in banning ephedra-containing products? Drug Topics. 2004; 148(5):68,71.
Koumis T, Nathan JP, Rosenberg JM. What is the role of C- reactive protein in cardiovascular disease assessment and how do you treat elevated levels? Drug Topics. 2003; 147(15):30.
Koumis T, Nathan JP, Rosenberg JM. Can grapefruit juice be safely taken with drugs? Drug Topics. 2002; 146(20):19.
Join the LIU Community!
We can't wait to welcome you to Shark Nation.
The application process is quick and easy, but if you have
any questions, our admissions counselors are here to help.